Rasagiline methanesulfonate
- Level
- Commodity
- Parent
- 51142500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142569This classification denotes a monoamine oxidase inhibitor and antiparkinsonian agent with the molecular formula C12H13N.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LH8C2JI290, chemically known as (r)-n-2-propynyl-1-indanamine methanesulfonate, but more generally known as rasagiline methanesulfonate, which bears US NIH Compound Identifier 3052775. European Medicines Agency schedules rasagiline methanesulfonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10261MIG. Most nations, for tariff purposes, schedule rasagiline methanesulfonate under HS 29214980. SMILES: CS(=O)(=O)O.C#CCN[C@@H]1CCC2C1CCCC2.
Same parent
Under 51142500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.